Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations
Clinical trial NCT07328919 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07328919
- Sponsor
- TransThera Sciences (Nanjing), Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2029-12-31
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.